All Stories

  1. Prevention of Infection in Adults Receiving Intravenous Antibiotic Treatment via Indwelling Central Venous Access Devices
  2. Biochemical and Haematological Predictors of Reduced Neutrophil Granulocyte Count associated with Intravenous Ceftriaxone Treatment
  3. Application of Bayesian decision-making to laboratory testing for Lyme disease and comparison with testing for HIV
  4. Desensitization to chemical and food sensitivities by low-dose immunotherapy ascertained by provocation neutralization is associated with reduced influx of calcium ions into lymphocytes
  5. Recovery from Cogwheel Rigidity and Akinesia and Improvement in Vibration Sense and Olfactory Perception following Removal of an Epoxy-Oleic Acid DNA Adduct
  6. Co-administration of α-lipoic acid and glutathione is associated with no significant changes in serum bilirubin, alkaline phosphatase or γ-glutamyltranspeptidase levels during the treatment of neuroborreliosis with intravenous ceftriaxone
  7. Association of KIBRA rs17070145 polymorphism with episodic memory in the early stages of a human neurodevelopmental disorder
  8. Hyperosmia in Lyme disease
  9. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials
  10. The effect of pulsed electromagnetic field therapy on food sensitivity
  11. Neurological and neuroimaging signs of reversible Parkinsonism associated with manganese exposure
  12. Respiratory modulation of cardiac vagal tone in Lyme disease
  13. Respiratory modulation of cardiac vagal tone in Lyme disease
  14. Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience: Third Edition, by David P. Moore & Basant K. Puri, Hodder Arnold, London, 2012, ISBN-13 978-1-4441-2134-6 (Hardback)
  15. Omega-3 Fatty Acids in Intellectual Disability, Schizophrenia, Depression, Autism, and Attention-Deficit Hyperactivity Disorder
  16. The Association of Lyme Disease With Loss of Sexual Libido and the Role of Urinary Bladder Detrusor Dysfunction
  17. Revision Notes in Psychiatry, Third Edition
  18. The risk of lead contamination in bone broth diets
  19. Drugs in Psychiatry
  20. Drug treatment and psychiatry
  21. The principles of psychopharmacology
  22. Non-depot antipsychotic drugs
  23. Antipsychotic depot injections
  24. Treatment-resistant schizophrenia
  25. Antimanic drugs
  26. Tricyclic and related antidepressant drugs
  27. Monoamine-oxidase inhibitors
  28. Selective serotonin re-uptake inhibitors
  29. Other and newer antidepressants
  30. Treatment-resistant depression
  31. Other drugs used in psychiatry
  32. Recent Developments in Neurochemical Imaging in Schizophrenia: An Update
  33. Recent Developments in Neurochemical Imaging in Schizophrenia: An Update
  34. Urinary Bladder Detrusor Dysfunction Symptoms in Lyme Disease
  35. Provision of spiritual and pastoral care facilities in a high-security hospital and their increased use by those of Muslim compared to Christian faith
  36. Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience, Third Edition
  37. Effects of PUFA supplementation evidenced by brain imaging
  38. Brain tissue changes and antipsychotic medication
  39. Neurobiology and phenotypic expression in early onset schizophrenia
  40. The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia
  41. Spatial normalization of BOLD fMRI data in cases of qualitative gross neuroanatomical changes resulting from pathology
  42. Diffusion-weighted imaging signal hyperintensity in subacute combined degeneration of the spinal cord
  43. What insights can we gain from studying early-onset schizophrenia? The neurodevelopmental pathway and beyond
  44. Prevalence of cataract in adult Down's syndrome patients
  45. EPA and Huntington's chorea: treatment and associated cerebral changes
  46. The pharmacotherapy of depression with EPA
  47. Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia
  48. Structural brain changes in patients with Huntington's disease participating in a randomized, double-blind, placebo-controlled trial of ethyl-eicosapentaenoic acid
  49. Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended
  50. Regional grey matter volumetric changes in forensic schizophrenia patients: a magnetic resonance imaging study comparing the brain structure of patients who have seriously and violently offended with those of patients who have not
  51. Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?
  52. The Role of Modern Western Diets in Attention-Deficit Hyperactivity Disorder
  53. Do Modern Western Diets Play a Role in Myalgic Encephalomyelitis?
  54. Copy Number Variation, Eicosapentaenoic Acid and Neurological Disorders
  55. Progressive structural brain changes in schizophrenia
  56. Copy Number Variation, Eicosapentaenoic Acid and Neurological Disorders. With Particular Reference to Huntington's Disease and Associated CAG Repeats, and to Myalgic Encephalomyelitis and Viral Infection
  57. The association of patent foramen ovale transcatheter closure and psychological well-being
  58. The electroencephalogram and evoked potential studies Caroline Brown and Jonathan Bird
  59. Psychiatry: An evidence-based text
  60. Classification and diagnostic systems Pesach Lichtenberg and RH Belmaker
  61. Marital therapy David Hewison
  62. Neuroanatomy Basant K Puri and Bari M Logan
  63. Emergency psychiatry
  64. Social science and sociocultural psychiatry Mary Boulton
  65. Neurophysiology of integrated behaviour
  66. Magnetic resonance spectroscopy in psychiatry
  67. Neuropsychiatric disorders presenting with antisocial behaviour
  68. Fatty acids and neuropsychiatric disorders
  69. Fatty acids and oxidative stress
  70. The use of artificial neural networks to study fatty acids in neuropsychiatric disorders
  71. Cerebral spectroscopic and oxidative stress studies in patients with schizophrenia who have dangerously violently offended
  72. Fatty acids and oxidative stress in psychiatric disorders
  73. Smoking and neuropsychiatric disorders: a comparison of oxidative stress in smokers compared with non-smokers
  74. Changes in the cerebral cortex in forensic schizophrenia patients: a magnetic resonance imaging study
  75. Cerebral spectroscopic and oxidative stress studies in patients with schizophrenia who have dangerously violently offended
  76. Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans
  77. A comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation
  78. Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia
  79. Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended
  80. Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans
  81. Regional grey matter volumetric changes in forensic schizophrenia patients: an MRI study comparing the brain structure of patients who have seriously and violently offended with that of patients who have not
  82. Ethane as a biomarker of schizophrenia
  83. Prevalence of cataract in adult Down's syndrome patients
  84. Cardiovascular disease and depression: the PUFA connection
  85. Emergencies in Psychiatry
  86. Chapter 4 Aggression and violence
  87. Chapter 6 Homelessness, loneliness, and isolation
  88. Chapter 8 Alcohol misuse and dependence
  89. Chapter 9 Other psychoactive substance misuse
  90. Chapter 22 Emergencies in forensic psychiatry
  91. Chapter 1 The assessment of psychiatric emergencies
  92. Chapter 2 The management of psychiatric and medical emergencies
  93. Chapter 3 Psychiatric symptoms and syndromes presenting as emergencies
  94. Chapter 5 Victims of abuse, violence, and disaster
  95. Chapter 7 Deliberate self-harm and suicide
  96. Chapter 10 Emergencies related to psychotropic drug actions
  97. Chapter 11 Psychiatric emergencies in accident and emergency departments
  98. Chapter 12 Psychiatric emergencies in general hospital medical wards
  99. Chapter 14 Psychiatric emergencies in obstetrics and gynaecology
  100. Chapter 15 Psychiatric emergencies in children and adolescents
  101. Chapter 16 Psychiatric emergencies in people with learning disabilities
  102. Chapter 17 Emergencies in old-age psychiatry
  103. Chapter 18 Emergencies in psychiatry in primary care
  104. Chapter 20 Mental health legislation relevant to emergencies in psychiatry
  105. Chapter 21 Difficult patients and difficult situations
  106. Chapter 13 Psychiatric emergencies in surgical, radiotherapy, oncology, and terminally ill patients
  107. Chapter 19 Assertive outreach, crisis resolution and intensive home treatment teams, and early intervention services
  108. The Essentiality of Eicosapentaenoic Acid in Breast Milk During Human Lactation
  109. Serial Structural MRI Analysis and Proton and <sup>31</sup>PMR Spectroscopy in the Investigation of Cerebral Fatty Acids in Major Depressive Disorder, Huntington’s Disease, Myalgic Encephalomyelitis and in Forensic Schizophrenic P...
  110. The human mirror system: A motor resonance theory of mind-reading
  111. Blood-injection-injury phobias
  112. Drug-facilitated sexual assaults
  113. Prevalence of cataract in adult Down's syndrome patients aged 28 to 83 years
  114. Munchausen syndrome by proxy in pregnancy
  115. The rising tide of aggression and delinquency in adolescent girls
  116. Mental health law—a practical guide. Basant K. Puri, Robert A. Brown, Heather J. McKee and Ian H. Treasaden. Hodder Arnold, London, 2005, Pages: 254
  117. Lipids and Depression
  118. Treatment of Huntington’s Disease With Eicosapentaenoic Acid
  119. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia
  120. High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions ...
  121. Hypothermia and Amiloride Preserve Energetics in a Neonatal Brain Slice Model
  122. In vitro 1H-magnetic resonance spectroscopy of Barrett's esophageal mucosa using magic angle spinning techniques
  123. Professor David F. Horrobin 1939–2003: A tribute
  124. The clinical advantages of cold-pressed non-raffinated evening primrose oil over refined preparations
  125. Magnetic resonance imaging of the liver with ultrashort TE (UTE) pulse sequences
  126. Normal phospholipid-related signal transduction in autism
  127. EMG responses to transcranial magnetic stimulation of the motor cortex in schizophrenia
  128. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties
  129. Reduction in IQ in patients with schizophrenia who have seriously and dangerously violently offended
  130. MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment
  131. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia
  132. Eicosapentaenoic Acid in Treatment-Resistant Depression
  133. Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes
  134. Impaired Phospholipid‐Related Signal Transduction in Advanced Huntington's Disease
  135. Corticospinal Inhibition Appears Normal in Patients with Chronic Fatigue Syndrome
  136. FLAIR imaging using nonselective inversion pulses combined with slice excitation order cycling and k‐space reordering to reduce flow artifacts
  137. MRI changes in multiple sclerosis following treatment with lofepramine and l-phenylalanine
  138. Contributions of an Adiabatic Initial Inversion Pulse and K-space Re-ordered by Inversion-time at each Slice Position (KRISP) to Control of CSF Artifacts and Visualization of the Brain in FLAIR Magnetic Resonance Imaging
  139. A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration
  140. SPECT neuroimaging in schizophrenia with religious delusions
  141. Evaluation of a FLAIR Sequence Designed to Reduce CSF and Blood Flow Artifacts by Use of k-Space Reordered by Inversion Time at Each Slice Position (KRISP) in High Grade Gliomas of the Brain
  142. Laterality changes accompanying symptom remission in schizophrenia following treatment with eicosapentaenoic acid
  143. Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia
  144. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy
  145. Increased cyclooxygenase/lipooxygenase acfivity in platelets from schizophrenic subjects indicates impaired arachidonic acid metabolism
  146. Transcranial magnetic stimulation in psychiatric research
  147. MRI and MRS of Neuropsychiatry
  148. Letters to the Editor
  149. The treatment of refractory depression using paroxetine with lithium augmentation
  150. Parietal scalp hair whorl patterns in schizophrenia
  151. Acute Disseminated Encephalomyelitis Presenting as an Acute Psychotic State
  152. SPECT in Adult Mosaic Downʼs Syndrome With Early Dementia
  153. Cerebral hemiatrophy and schizophrenia
  154. Self-inflicted intracranial injury
  155. Clozapine: progress in treating refractory schizophrenia.
  156. The use of computerised tomography in mental handicap patients
  157. High rate of Section 4 admissions: clinical implications and possible explanation
  158. A psychiatric trainee's experience of holding the burden